Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

First identification, chemical analysis and pharmacological characterization of N-piperidinyl etonitazene (etonitazepipne), a recent addition to the 2-benzylbenzimidazole opioid subclass
Marthe M. Vandeputte, Nick Verougstraete, Donna Walther, et al.
Archives of Toxicology (2022) Vol. 96, Iss. 6, pp. 1865-1880
Closed Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Pharmacological evaluation and forensic case series of N-pyrrolidino etonitazene (etonitazepyne), a newly emerging 2-benzylbenzimidazole ‘nitazene’ synthetic opioid
Marthe M. Vandeputte, Alex J. Krotulski, Donna Walther, et al.
Archives of Toxicology (2022) Vol. 96, Iss. 6, pp. 1845-1863
Open Access | Times Cited: 50
Human metabolism of four synthetic benzimidazole opioids: isotonitazene, metonitazene, etodesnitazene, and metodesnitazene
Omayema Taoussi, Diletta Berardinelli, Simona Zaami, et al.
Archives of Toxicology (2024) Vol. 98, Iss. 7, pp. 2101-2116
Open Access | Times Cited: 13
Method development for the quantification of nine nitazene analogs and brorphine in Dried Blood Spots utilizing liquid chromatography – tandem mass spectrometry
Christina Ververi, Martina Galletto, Marta Massano, et al.
Journal of Pharmaceutical and Biomedical Analysis (2024) Vol. 241, pp. 115975-115975
Open Access | Times Cited: 10
In vitro, in vivo metabolism and quantification of the novel synthetic opioid N-piperidinyl etonitazene (etonitazepipne)
Diletta Berardinelli, Omayema Taoussi, Jérémy Carlier, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2024) Vol. 62, Iss. 8, pp. 1580-1590
Closed Access | Times Cited: 10
In vitro structure–activity relationships and forensic case series of emerging 2-benzylbenzimidazole ‘nitazene’ opioids
Liam M. De Vrieze, Sara E. Walton, Eline Pottie, et al.
Archives of Toxicology (2024) Vol. 98, Iss. 9, pp. 2999-3018
Open Access | Times Cited: 10
Case series of severe intoxications associated with new psychoactive substances on Reunion Island: Clinical description and diagnostic challenges
N. Negrault, B. Puech, Joris Guyon, et al.
Annales de Toxicologie Analytique (2025)
Open Access | Times Cited: 1
The UHPLC-MS/MS method for the determination of 26 synthetic benzimidazole opioids (nitazene analogs) with isomers separation
Olga Wachełko, Kaja Tusiewicz, Paweł Szpot, et al.
Journal of Pharmaceutical and Biomedical Analysis (2025) Vol. 260, pp. 116796-116796
Closed Access | Times Cited: 1
Comparative neuropharmacology of structurally distinct non-fentanyl opioids that are appearing on recreational drug markets worldwide
Marthe M. Vandeputte, Meng-Hua M. Tsai, Li Chen, et al.
Drug and Alcohol Dependence (2023) Vol. 249, pp. 109939-109939
Closed Access | Times Cited: 22
Non-fentanyl new synthetic opioids – An update
Jolanta B. Zawilska, Piotr Adamowicz, Marta Kurpeta, et al.
Forensic Science International (2023) Vol. 349, pp. 111775-111775
Closed Access | Times Cited: 20
Alkoxy chain length governs the potency of 2-benzylbenzimidazole ‘nitazene’ opioids associated with human overdose
Grant C. Glatfelter, Marthe M. Vandeputte, Li Chen, et al.
Psychopharmacology (2023) Vol. 240, Iss. 12, pp. 2573-2584
Closed Access | Times Cited: 18
In vitro characterization of protonitazene metabolites, using human liver microsomes, and first application to two urines collected from death cases
Alice Ameline, Laurie Gheddar, Simona Pichini, et al.
Clinica Chimica Acta (2024) Vol. 561, pp. 119764-119764
Closed Access | Times Cited: 8
Pharmacological characterization of novel synthetic opioids: Isotonitazene, metonitazene, and piperidylthiambutene as potent μ-opioid receptor agonists
Maria Antonietta De Luca, Graziella Tocco, Rafaela Mostallino, et al.
Neuropharmacology (2022) Vol. 221, pp. 109263-109263
Open Access | Times Cited: 28
Identification of N-piperidinyl etonitazene in alternative keratinous matrices from a decomposing cadaver
Erika Buratti, Gianmario Mietti, Alice Cerioni, et al.
Journal of Forensic and Legal Medicine (2024) Vol. 105, pp. 102710-102710
Closed Access | Times Cited: 4
Evaluation of enzyme‐linked immunosorbent assay screening kits for the detection of nitazene analogs
Amanda L. Pacana, Britni Skillman
Journal of Forensic Sciences (2025)
Closed Access
The Future of Deadly Synthetic Opioids: Nitazenes and Their International Control
Nicholas Lassi, Su Jiang
Global Policy (2025)
Closed Access
Navigating nitazenes: A pharmacological and toxicological overview of new synthetic opioids with a 2-benzylbenzimidazole core
Marthe M. Vandeputte, Christophe P. Stove
Neuropharmacology (2025), pp. 110470-110470
Closed Access
Interpol Review of Drug Analysis 2019-2022
David J. Love, Nicole S. Jones
Forensic Science International Synergy (2023) Vol. 6, pp. 100299-100299
Open Access | Times Cited: 10
The novel psychoactive substances epidemic: A scientometric perspective
Michelle Jin Yee Neoh, Alessandro Carollo, Mengyu Lim, et al.
Addiction Neuroscience (2022) Vol. 5, pp. 100060-100060
Open Access | Times Cited: 11
Detecting novel psychoactive substances around the world
Alberto Salomone, Marco Vincenti
Current Opinion in Psychiatry (2024) Vol. 37, Iss. 4, pp. 258-263
Closed Access | Times Cited: 2
Activity-based detection of synthetic cannabinoid receptor agonists in plant materials
A. J. Timmerman, Margot Balcaen, Vera Coopman, et al.
Harm Reduction Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 2
A model of evaluative opinion to encourage greater transparency and justification of interpretation in postmortem forensic toxicology
Peter Maskell, Simon Elliott, Brigitte Desharnais, et al.
Journal of Analytical Toxicology (2023) Vol. 47, Iss. 7, pp. 563-573
Open Access | Times Cited: 4
Elucidating the harm potential of brorphine analogues as new synthetic opioids: Synthesis, in vitro, and in vivo characterization
Marthe M. Vandeputte, Sabrine Bilel, Micaela Tirri, et al.
Neuropharmacology (2024) Vol. 260, pp. 110113-110113
Closed Access | Times Cited: 1
Structural characterization of nitazene analogs using electron ionization-mass spectrometry (EI-MS)
Emma K. Hardwick, J. Tyler Davidson
Forensic Chemistry (2024) Vol. 40, pp. 100605-100605
Closed Access | Times Cited: 1
Respiratory Depression Associated with Opioids: A Narrative Review
Mellar P. Davis, Sandra DiScala, Amy L. Davis
Current Treatment Options in Oncology (2024) Vol. 25, Iss. 11, pp. 1438-1450
Closed Access | Times Cited: 1
Characterization of novel nitazene recreational drugs: Insights into their risk potential from in vitro µ-opioid receptor assays and in vivo behavioral studies in mice
Marthe M. Vandeputte, Grant C. Glatfelter, Donna Walther, et al.
Pharmacological Research (2024) Vol. 210, pp. 107503-107503
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top